2009
DOI: 10.2478/v10133-009-0022-6
|View full text |Cite
|
Sign up to set email alerts
|

Cytogenetic Clonal Evolution in Patients with Chronic Myeloid Leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…We have published our results on clonal chromosome abnormalities other than the Ph chromosome in Ph+ and Ph- cells of CML patients who were followed in our center a few years ago [ 2 , 3 ]. Monosomies were the most frequently observed chromosome abnormalities in these reports.…”
Section: To the Editormentioning
confidence: 99%
“…We have published our results on clonal chromosome abnormalities other than the Ph chromosome in Ph+ and Ph- cells of CML patients who were followed in our center a few years ago [ 2 , 3 ]. Monosomies were the most frequently observed chromosome abnormalities in these reports.…”
Section: To the Editormentioning
confidence: 99%
“…As previously described, patients were diagnosed with CML-AP based on the standard definition (i.e., hematologic criteria 4 or clonal evolution); patients with progression of a prior CML-AP diagnosis after achieving a hematologic response were also eligible 4 . Clonal evolution included additional chromosomal abnormalities besides the Ph chromosome (e.g., +8, +19, iso17q) 8 . After 2 years, patients who experienced-specific AEs (e.g., any-grade recurring fluid retention, including pleural and/or pericardial effusion, or any-grade gastrointestinal bleed despite dose reduction by one level) were allowed to switch from BID to QD dosing, but data were analyzed based on the initial randomization arm.…”
mentioning
confidence: 99%